المؤلفون: Abdel-Razeq H, Sharaf B, Khater S, Baidoun HJ, Bani Hani H, Taqash A, El Khatib O, Edaily S, Abunasser M, Tamimi F, Al-Masri YN, Al-Batsh TMW, Zayed A, Ghatasheh T, Radaideh T

المصدر: ImmunoTargets and Therapy, Vol Volume 13, Pp 501-512 (2024)

مصطلحات موضوعية: metastatic breast cancer, mbc, cdk4/6 inhibitors, ribociclib, aromatase inhibitors, fulvestrant, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

Relation: https://www.dovepress.com/clinical-outcomes-of-patients-treated-with-ribociclib-in-combination-w-peer-reviewed-fulltext-article-ITT; https://doaj.org/toc/2253-1556

URL الوصول: https://doaj.org/article/a11cfe5e6ffa41b2b2eca6ea7b3bc8f7